Difference between revisions of "Calculation models"
From Testiwiki
(→References) |
Juha Villman (talk | contribs) m (7 revisions: moved from Intarese wiki) |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 15: | Line 15: | ||
* [[Exposed population]] | * [[Exposed population]] | ||
− | We need the accumulated exposure. I.e. the sum of ("the concentration per grid cell" by "population living there"). | + | We need the accumulated exposure. I.e. the sum of ("the concentration change per grid cell" by "population living there"). |
=== Data === | === Data === | ||
+ | * Particles < 2.5 µm | ||
+ | |||
+ | {| border="1" | ||
+ | ! Health endpoints | ||
+ | ! Risk group fraction | ||
+ | ! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) | ||
+ | |- valign="top" | ||
+ | | Life expectancy reduction - YOLLchronic | ||
+ | | Adults_30andAbove | ||
+ | | 18,228 | ||
+ | |- valign="top" | ||
+ | | New cases of chronic bronchitis (1) | ||
+ | | Adults_27andAbove | ||
+ | | 7,462 | ||
+ | |- valign="top" | ||
+ | | Restricted activity days (RADs) | ||
+ | | Adults_15_to_64_years | ||
+ | | 7,879872 | ||
+ | |- valign="top" | ||
+ | | Work loss days (WLD) | ||
+ | | Adults_15_to_64_years | ||
+ | | 1,1406528 | ||
+ | |- valign="top" | ||
+ | | Minor restricted activity days (MRAD) | ||
+ | | Adults_18_to_64_years | ||
+ | | 1,403264 | ||
+ | |- valign="top" | ||
+ | |} | ||
+ | |||
+ | |||
+ | * Particles < 10 µm | ||
+ | |||
+ | {| border="1" | ||
+ | ! Health endpoints | ||
+ | ! Risk group fraction | ||
+ | ! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) | ||
+ | |- valign="top" | ||
+ | | Respiratory hospital admissions | ||
+ | | Total | ||
+ | | 0,01406 | ||
+ | |- valign="top" | ||
+ | | Cardiac hospital admissions | ||
+ | | Total | ||
+ | | 0,00868 | ||
+ | |- valign="top" | ||
+ | | Medication use / bronchodilator use | ||
+ | | Children_PEACE_criteria_for_asthma_5_to_14 | ||
+ | | 0,0004032 | ||
+ | |- valign="top" | ||
+ | | Medication use / bronchodilator use | ||
+ | | Adults_20andAbove_asthmatics | ||
+ | | 0,022344 | ||
+ | |- valign="top" | ||
+ | | Lower respiratory symptoms (adult) | ||
+ | | Adults_symptomatic_adults | ||
+ | | 1,2103 | ||
+ | |- valign="top" | ||
+ | | Lower respiratory symptoms (child) | ||
+ | | Children_5_to_14_years | ||
+ | | 0,791616 | ||
+ | |- valign="top" | ||
+ | |} | ||
+ | |||
+ | * Ozone | ||
+ | |||
+ | {| border="1" | ||
+ | ! Health endpoints | ||
+ | ! Risk group fraction | ||
+ | ! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) | ||
+ | |- valign="top" | ||
+ | | Increased mortality risk | ||
+ | | Total | ||
+ | | 0,049315068 | ||
+ | |- valign="top" | ||
+ | | Respiratory hospital admissions | ||
+ | | Elderly_65andAbove | ||
+ | | 1,08219E-05 | ||
+ | |- valign="top" | ||
+ | | MRAD | ||
+ | | Adults_18_to_64_years | ||
+ | | 0,000766247 | ||
+ | |- valign="top" | ||
+ | | Medication use / bronchodilator use | ||
+ | | Adults_20andAbove_asthmatics | ||
+ | | 0,000049 | ||
+ | |- valign="top" | ||
+ | | LRS excluding cough | ||
+ | | Children_5_to_14_years | ||
+ | | 0,000186564 | ||
+ | |- valign="top" | ||
+ | | Cough days | ||
+ | | Children_5_to_14_years | ||
+ | | 0,001084405 | ||
+ | |- valign="top" | ||
+ | |} | ||
+ | |||
+ | (Please notice that these data are newly developed by NEEDS and not yet published!!!!!) | ||
=== Formula === | === Formula === | ||
Line 30: | Line 127: | ||
− | + | [[category:Kuopio workshop]] | |
+ | [[category:Intarese]] |
Latest revision as of 10:53, 20 November 2009
If you need help about filling in a variable open the link at the end of this paragraph in a new window. Otherwise, just delete this paragraph and start writing.
Scope
Calculation describes
Contents
Description
References
- NEEDS ExternE methodology [1] (new figures)
Definition
Causality
List of parents:
We need the accumulated exposure. I.e. the sum of ("the concentration change per grid cell" by "population living there").
Data
- Particles < 2.5 µm
Health endpoints | Risk group fraction | Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) |
---|---|---|
Life expectancy reduction - YOLLchronic | Adults_30andAbove | 18,228 |
New cases of chronic bronchitis (1) | Adults_27andAbove | 7,462 |
Restricted activity days (RADs) | Adults_15_to_64_years | 7,879872 |
Work loss days (WLD) | Adults_15_to_64_years | 1,1406528 |
Minor restricted activity days (MRAD) | Adults_18_to_64_years | 1,403264 |
- Particles < 10 µm
Health endpoints | Risk group fraction | Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) |
---|---|---|
Respiratory hospital admissions | Total | 0,01406 |
Cardiac hospital admissions | Total | 0,00868 |
Medication use / bronchodilator use | Children_PEACE_criteria_for_asthma_5_to_14 | 0,0004032 |
Medication use / bronchodilator use | Adults_20andAbove_asthmatics | 0,022344 |
Lower respiratory symptoms (adult) | Adults_symptomatic_adults | 1,2103 |
Lower respiratory symptoms (child) | Children_5_to_14_years | 0,791616 |
- Ozone
Health endpoints | Risk group fraction | Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions) |
---|---|---|
Increased mortality risk | Total | 0,049315068 |
Respiratory hospital admissions | Elderly_65andAbove | 1,08219E-05 |
MRAD | Adults_18_to_64_years | 0,000766247 |
Medication use / bronchodilator use | Adults_20andAbove_asthmatics | 0,000049 |
LRS excluding cough | Children_5_to_14_years | 0,000186564 |
Cough days | Children_5_to_14_years | 0,001084405 |
(Please notice that these data are newly developed by NEEDS and not yet published!!!!!)
Formula
Analytica_id:
<anacode></anacode>